Submitted by Anonymous (not verified) on 25 April 2024 - 9:40
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 5, Status: Authorised
Source: